NYSE: ADCTAdc Therapeutics Sa Stock Ownership - Who owns Adc Therapeutics Sa?
Insider buying vs selling
Have Adc Therapeutics Sa insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ameet Mallik | Chief Executive Officer | 2025-05-06 | 26,758 | $1.29 | $34.52kSell |
| Ameet Mallik | Chief Executive Officer | 2025-02-13 | 650,000 | $1.61 | $1.05MBuy |
| Lisa Michelle Kallebo | Chief Accounting Officer | 2025-02-13 | 41,900 | $1.61 | $67.46kBuy |
| Mohamed Zaki | Chief Medical Officer | 2025-02-13 | 230,000 | $1.61 | $370.30kBuy |
| Jose Carmona | Chief Financial Officer | 2025-02-13 | 240,000 | $1.61 | $386.40kBuy |
| Peter J. Graham | Chief Legal Officer | 2025-02-13 | 220,000 | $1.61 | $354.20kBuy |
| Redmile Group LLC | 10% Owner | 2024-12-11 | 50,000 | $3.81 | $190.50kBuy |
| Redmile Group LLC | 10% Owner | 2024-12-11 | 50,000 | $2.28 | $114.00kBuy |
| Redmile Group LLC | 10% Owner | 2024-12-11 | 50,000 | $3.81 | $190.50kBuy |
| Redmile Group LLC | 10% Owner | 2024-12-11 | 50,000 | $2.28 | $114.00kBuy |
ADCT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ADCT insiders and whales buy or sell their stock.
ADCT Shareholders
What type of owners hold Adc Therapeutics Sa stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Redmile Group LLC | 29.05% | 28,812,443 | $54.46M | Insider |
| Redmile Group LLC | 15.80% | 15,666,731 | $29.61M | Institution |
| Hans Peter Wild | 9.87% | 9,788,944 | $18.50M | Insider |
| Prosight Management LP | 9.62% | 9,543,004 | $18.04M | Institution |
| Orbimed Advisors LLC | 6.02% | 5,968,451 | $11.28M | Institution |
| Blackrock Inc | 4.95% | 4,913,628 | $9.29M | Institution |
| Morgan Stanley | 3.04% | 3,019,585 | $5.71M | Institution |
| Platinum Investment Management Ltd | 2.05% | 2,038,087 | $3.85M | Institution |
| Bank Of America Corp | 1.82% | 1,801,154 | $3.40M | Institution |
| Goldman Sachs Group Inc | 1.60% | 1,583,112 | $2.99M | Institution |
ADCT vs Biotech Stocks
Adc Therapeutics Sa Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.